C-MER Medical Holdings Limited (Stock Code: 03309) announced that on 26 November 2025, 160,000 ordinary shares were repurchased on the market at prices ranging from HKD 1.72 to HKD 1.74 each, totaling HKD 277,200. Following this transaction, the issuer holds 17,448,000 treasury shares, while its number of issued shares (excluding treasury shares) stands at 1,238,112,870.

The issuer also disclosed that a series of share repurchases for cancellation remain outstanding, dating from July 2024 through May 2025. These repurchased shares have not yet been cancelled but continue to be accounted for in the overall share capital figures.

Under the latest repurchase mandate passed on 19 May 2025, the issuer is authorized to repurchase up to 125,556,087 shares. The newly completed transaction on 26 November 2025 represents approximately 0.0129% of the issued shares on the date of the resolution granting this mandate. A moratorium on any new issue of shares or sale or transfer of treasury shares runs until 26 December 2025, in line with applicable listing rules and regulations.